Accelerate to discover
Related topics
Oct 20, 2021
Ionizing radiation approaches are effective but use of radioactive radioisotopic elements have become difficult to...
Duke uses XRAD 225 CX to test radiosensitivity hypothesis
Oct 18, 2021
Image guided radiotherapy in a preclinical setting couldn’t be more useful than the treatment of brain tumors, where...
Curiox webinar: Laminar Wash enables single-cell multiomics and cell hashing
Oct 11, 2021
Professor Mats Bemark’s lab at the University of Gothenburg in Sweden studies how the immune system responds to...
Falling in love with Magnetic resonance
Oct 4, 2021
Magnetic Resonance (MR) is more than just analytical science, it is unique, it is a passion that won’t let you go
The roles of preclinical optical imaging in cancer research
Sep 22, 2021
Watch the last Spectral Instrument Imaging webinar with Dr. Michael Henry who will shares key data sets from his work...
See What's Possible with the PippinHT
Sep 14, 2021
Programmable DNA size selection enables new discoveries by helping optimize the library detected by a sequencer. That’s...
Magnetic resonance elastography techniques and preclinical applications
Sep 14, 2021
It has been known for centuries that tissue stiffness can change in the presence of disease, but quantifying such...
Ex Vivo dental imaging is directly translatable to the clinic
Sep 14, 2021
Although patients are too large in size for preclinical microCT scanners, it still has a big significance in clinical...
Mar 22, 2016
The mutations driving cancer create clonal populations that differ not just between cancer patients, but within individual tumors. These mutations contain small but significant populations which may survive treatment and metastasize. The only method to get a complete picture of tumor clonality is by sequencing single cells.
In this webinar, you will learn how you can make breakthrough discoveries in your research using single-cell DNA Sequencing. Dr. Ioannis Ragoussis of McGill University will share his research using single-cell whole exome sequencing to reveal the true heterogeneity and cell lineages present in triple negative breast cancer.
Brand profile
Fluidigm is a Molecular and Single Cell Biology company that creates microfluidic-based chips and instrumentation for Life-Science research.
More info at:
www.fluidigm.com/
BioFocus newsletter
Register to receive Brand new technology development, Important product updates, Interesting scientific events and more!
BioTech a.s. © 2014
Designed & developed by imagineit
Technologies
